Despite the regulatory approval of new antiepileptic drugs (AED) over the past decade and the expansion of indications deemed suitable for epilepsy surgery, individuals with intractable seizures – roughly one in three epilepsy patients – still face a dearth of…
It’s that time of year, when some thoughts turn to sugar plum fairies and others to the J.P. Morgan Healthcare Conference – or JPM#13 as it’s now widely known. Before you pop the cork on another New Year, however, it’s…
With the 2012 BIO International Convention behind us and the Fourth of July signaling summer vacation season in earnest, thoughts turn to visions of sun, sand and afternoons lounging in a deck chair. Again this year, BioWorld polled biotech execs,…
BOSTON – The 2012 BIO International Convention may have fallen a tad short of its nadir in 2007, when BIO attendance topped more than 20,000 people from 49 U.S. states, Washington D.C., Puerto Rico and more than 60 countries.
At a family wedding earlier this month, an uncle was salivating over the prospect that the Vivus Inc. drug Qnexa could soon become the first in a new generation of obesity drugs to gain FDA approval. He needed to lose…
Join the Conversation